Works matching AU Mizokami, Atsushi

Results: 220
    1

    Enzalutamide versus abiraterone as a first-line endocrine therapy for castration-resistant prostate cancer (ENABLE study for PCa): a study protocol for a multicenter randomized phase III trial.

    Published in:
    2017
    By:
    • Kouji Izumi;
    • Atsushi Mizokami;
    • Mikio Namiki;
    • Shogo Inoue;
    • Nobumichi Tanaka;
    • Yuko Yoshio;
    • Kei Ishibashi;
    • Manabu Kamiyama;
    • Noriyasu Kawai;
    • Hideki Enokida;
    • Takashi Shima;
    • Shizuko Takahara;
    • Izumi, Kouji;
    • Mizokami, Atsushi;
    • Namiki, Mikio;
    • Inoue, Shogo;
    • Tanaka, Nobumichi;
    • Yoshio, Yuko;
    • Ishibashi, Kei;
    • Kamiyama, Manabu
    Publication type:
    journal article
    2
    3

    Efficacy and Safety of Enzalutamide and Abiraterone Plus Prednisolone in Elder Castration‐Resistant Prostate Cancer Patients: A Sub‐Analysis From the ENABLE Study.

    Published in:
    Prostate, 2025, v. 85, n. 10, p. 903, doi. 10.1002/pros.24897
    By:
    • Okamura, Takehiko;
    • Izumi, Kouji;
    • Kurokawa, Satoshi;
    • Shima, Takashi;
    • Kato, Yuki;
    • Mita, Koji;
    • Kamiyama, Manabu;
    • Inoue, Shogo;
    • Hoshi, Seiji;
    • Tanaka, Nobumichi;
    • Yoshio, Yuko;
    • Enokida, Hideki;
    • Chikazawa, Ippei;
    • Kawai, Noriyasu;
    • Hashimoto, Kohei;
    • Fukagai, Takashi;
    • Shigehara, Kazuyoshi;
    • Takahara, Shizuko;
    • Mizokami, Atsushi
    Publication type:
    Article
    4
    5
    6
    7
    8

    Hormonal therapy.

    Published in:
    International Journal of Clinical Oncology, 2007, v. 12, n. 6, p. 427, doi. 10.1007/s10147-007-0704-8
    By:
    • Namiki, Mikio;
    • Ueno, Satoru;
    • Kitagawa, Yasuhide;
    • Konaka, Hiroyuki;
    • Mizokami, Atsushi;
    • Koh, Eitetsu;
    • Fukagai, Takashi
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Favorable Response of Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma with Only Small Lesions to not be Considered Measurable by RECIST.

    Published in:
    Urology Journal, 2022, v. 19, n. 3, p. 202, doi. 10.22037/uj.v18i.6652
    By:
    • Yoshifumi Kadono;
    • Shohei Kawaguchi;
    • Takahiro Nohara;
    • Kazuyoshi Shigehara;
    • Kouji Izumi;
    • Taiki Kamijima;
    • Chikashi Seto;
    • Akinobu Takano;
    • Satoshi Yotsuyanagi;
    • Ryunosuke Nakagawa;
    • Tohru Miyagi;
    • Shuhei Aoyama;
    • Hideki Asahi;
    • Rie Fukuda;
    • Atsushi Mizokami
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29

    Japanese Expert Panel Meeting on the Management of Prostate Cancer with Bone Metastases.

    Published in:
    Oncology & Therapy, 2018, v. 6, n. 2, p. 157, doi. 10.1007/s40487-018-0088-0
    By:
    • Takahashi, Shunji;
    • Kinuya, Seigo;
    • Nonomura, Norio;
    • Shinohara, Nobuo;
    • Suzuki, Kazuhiro;
    • Suzuki, Hiroyoshi;
    • Nakamura, Katsumasa;
    • Satoh, Takefumi;
    • Tateishi, Ukihide;
    • Yoneda, Toshiyuki;
    • Horikoshi, Hiroyuki;
    • Igawa, Tsukasa;
    • Kamai, Takao;
    • Koizumi, Mitsuru;
    • Kosaka, Takeo;
    • Matsubara, Nobuaki;
    • Miyake, Hideaki;
    • Mizokami, Atsushi;
    • Mizowaki, Takashi;
    • Nakamura, Naoki
    Publication type:
    Article
    30
    31
    32

    FOXA1 Promotes Tumor Progression in Prostate Cancer via the Insulin-Like Growth Factor Binding Protein 3 Pathway.

    Published in:
    PLoS ONE, 2012, v. 7, n. 8, p. 1, doi. 10.1371/journal.pone.0042456
    By:
    • Imamura, Yusuke;
    • Sakamoto, Shinichi;
    • Endo, Takumi;
    • Utsumi, Takanobu;
    • Fuse, Miki;
    • Suyama, Takahito;
    • Kawamura, Koji;
    • Imamoto, Takashi;
    • Yano, Kojiro;
    • Uzawa, Katsuhiro;
    • Nihei, Naoki;
    • Suzuki, Hiroyoshi;
    • Mizokami, Atsushi;
    • Ueda, Takeshi;
    • Seki, Naohiko;
    • Tanzawa, Hideki;
    • Ichikawa, Tomohiko;
    • Agoulnik, Irina
    Publication type:
    Article
    33

    Etiologic role of human papillomavirus infection in bladder carcinoma.

    Published in:
    Cancer (0008543X), 2011, v. 117, n. 10, p. 2067, doi. 10.1002/cncr.25777
    By:
    • Shigehara, Kazuyoshi;
    • Sasagawa, Toshiyuki;
    • Kawaguchi, Shohei;
    • Nakashima, Takao;
    • Shimamura, Masayoshi;
    • Maeda, Yuji;
    • Konaka, Hiroyuki;
    • Mizokami, Atsushi;
    • Koh, Eitetsu;
    • Namiki, Mikio
    Publication type:
    Article
    34

    Prevalence of human papillomavirus infection in the oropharynx and urine among sexually active men: a comparative study of infection by papillomavirus and other organisms, including Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma spp., and Ureaplasma spp

    Published in:
    BMC Infectious Diseases, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2334-14-43
    By:
    • Kazufumi Nakashima;
    • Kazuyoshi Shigehara;
    • Shohei Kawaguchi;
    • Akira Wakatsuki;
    • Yoshitomo Kobori;
    • Kazuyoshi Nakashima;
    • Yasunori Ishii;
    • Masayoshi Shimamura;
    • Toshiyuki Sasagawa;
    • Yasuhide Kitagawa;
    • Atsushi Mizokami;
    • Mikio Namiki
    Publication type:
    Article
    35

    Prevalence of human papillomavirus infection in the oropharynx and urine among sexually active men: a comparative study of infection by papillomavirus and other organisms, including Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma spp., and Ureaplasma spp.

    Published in:
    2014
    By:
    • Nakashima, Kazufumi;
    • Shigehara, Kazuyoshi;
    • Kawaguchi, Shohei;
    • Wakatsuki, Akira;
    • Kobori, Yoshitomo;
    • Nakashima, Kazuyoshi;
    • Ishii, Yasunori;
    • Shimamura, Masayoshi;
    • Sasagawa, Toshiyuki;
    • Kitagawa, Yasuhide;
    • Mizokami, Atsushi;
    • Namiki, Mikio
    Publication type:
    journal article
    36
    37
    38

    Cyclooxygenase-2 promotes prostate cancer progression.

    Published in:
    Prostate, 2002, v. 53, n. 3, p. 232, doi. 10.1002/pros.10152
    By:
    • Fujita, Hiroshi;
    • Koshida, Kiyoshi;
    • Keller, Evan T.;
    • Takahashi, Yoshitake;
    • Yoshimito, Tanihiro;
    • Namiki, Mikio;
    • Mizokami, Atsushi
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50

    L‐type amino acid transporter 1 inhibitor JPH203 prevents the growth of cabazitaxel‐resistant prostate cancer by inhibiting cyclin‐dependent kinase activity.

    Published in:
    Cancer Science, 2024, v. 115, n. 3, p. 937, doi. 10.1111/cas.16062
    By:
    • Rii, Junryo;
    • Sakamoto, Shinichi;
    • Mizokami, Atsushi;
    • Xu, Minhui;
    • Fujimoto, Ayumi;
    • Saito, Shinpei;
    • Koike, Hidekazu;
    • Tamura, Takaaki;
    • Arai, Takayuki;
    • Yamada, Yasutaka;
    • Goto, Yusuke;
    • Sazuka, Tomokazu;
    • Imamura, Yusuke;
    • Suzuki, Kazuhiro;
    • Kanai, Yoshikatsu;
    • Anzai, Naohiko;
    • Ichikawa, Tomohiko
    Publication type:
    Article